Could primary hyperparathyroidism-related hypercalcemia induce hypercalcitoninemia?

Hormone Research in Paediatrics

Volumn 73, Issue 5, 2010, Pages 372-375

  Conte Devolx, B ^a   Morlet Barla, N ^a   Roux, F ^c   Sebag, F ^b   Henry, J F ^b   Niccoli, P ^a,d  

^a Diabète et Maladies Métaboliques   (France)

^b Service de Chirurgie Endocrinienne   (France)

^c TIMONE HOSPITAL   (France)

^d AIX MARSEILLE UNIVERSITY   (France)

Author keywords

Calcitonin; Hypercalcemia; NEM2A; Primary hyperparathyroidism

Indexed keywords

CALCITONIN; CALCIUM; PARATHYROID HORMONE;

ABNORMALLY HIGH SUBSTRATE CONCENTRATION IN BLOOD; ADULT; AGED; ARTICLE; CALCITONIN BLOOD LEVEL; CALCIUM BLOOD LEVEL; FEMALE; HUMAN; HYPERCALCEMIA; HYPERCALCITONINEMIA; MAJOR CLINICAL STUDY; MALE; MEASUREMENT; PARATHYROID HORMONE BLOOD LEVEL; PRIMARY HYPERPARATHYROIDISM; PRIORITY JOURNAL;

ADULT; AGED; AGED, 80 AND OVER; CALCITONIN; CALCIUM; FEMALE; HUMANS; HYPERCALCEMIA; HYPERPARATHYROIDISM, PRIMARY; MALE; MIDDLE AGED; MULTIPLE ENDOCRINE NEOPLASIA TYPE 2A; PARATHYROID GLANDS;

EID: 77954037592     PISSN: 16632818     EISSN: 16632826     Source Type: Journal    
DOI: 10.1159/000308170     Document Type: Article

References (25)

1. Cioppi F, Falchetti A, Masi L, Brandi ML: Dynamic investigation for evaluation of calcium metabolism and parathyroid function. J Endocrinol Invest 2003; 26: 83-91.
2. H i rsch PF, Ba r uc h H: I s ca lc iton i n a n i mp or-tant physiological substance? Endocrine 2003; 21:201-208.
3. Segond N, Jullienne A, Lasmoles F, Desplan C, Milhaud G, Moukhtar MS: Rapid increase of calcitonin-specific mRNA after acute hy-perca lcemia. Eur J Biochem 1984; 139: 209-215.
4. 2+. Eur J Clin Invest 2002; 32:669-673.
5. Bevilacqua M, Dominguez LJ, Righini V, et al: Dissimilar PTH, gastrin, and calcitonin responses to oral calcium and peptones in hypocalciuric hypercalcemia, primary hy-perparathyroidism, and normal subjects: a useful tool for differential diagnosis. J Bone Mineral Res 2006; 21: 406-412.
6. Ramirez JA, Goodman WG, Gornbein J, et al: Direct in vivo comparison of calcium-regulated parathyroid hormone secretion in nor ma l volu nteers a nd patient s w it h s econd-ary hyperparathyroidism. J Clin Endocrinol Metab 1993; 76: 1489-1494.
7. Tiegs RD, Body JJ, Barta JM, Heath H: Plasma calcitonin in primary hyperparathyroid-ism: failure of C-cell response to sustained hypercalcemia. J Clin Endocrinol Metab 1986; 63: 785-788.
8. Becker KL, Silva OL Wisneski LA, et al: Limited calcitonin reserve in primary hyper-parathyroidism. Am J Med Sci 1980; 280-285.
9. Kubler N, Krause U, Wagner PK, Beyer J, Rothmund M: The effect of high parathyroid hormone concentration on calcitonin in patients with primary hyperparathyroidism. Exp Clin Endocrinol 1987; 90: 324-330.
10. Parthemore JG, Deftos LJ: Calcitonin secretion in primary hyperparathyroidism. J Clin Endocrinol Metab 1979; 49: 223-226.
11. Mazzuoli GF, D'Erasmo E, Scarda A et al: Calcitonin secretion and bone disease severity in hypercalcaemic hyperparathyroidism. Clin Endocrinol 1981; 15:81-86.
12. Tabol l i S, Va ltor ta C, Big i F, M i nisola S, Ma z-zuoli GF: Basal and stimulated calcitonin secretion in primary hyperparathyroidism before and after parathyroidectomy. Horm Res 1986; 23:142-146.
13. Brandi ML, Gagel RF, Angeli A, Bilezikian JP, et al: Guidelines for diagnosis and therapy of MEN type 1 and type 2. J Clin Endocri-nol Metab 2001; 86:5658-5671.
14. Motte P, Vauzelle P, Gardet P, et al: Construction and clinical validation of a sensitive and specific assay for serum mature cal-citonin using monoclonal anti-peptide antibodies Clin Chim Acta 1988; 174:35-54.
15. Barbot N, Calmettes C, Schuffenecker I, et al: Pentagastrin stimulation test and early diagnosis of medullary carcinoma using an im-munoradiometric assay of calcitonin: comparison with genetic screening in hereditary medullary thyroid carcinoma. J Clin Endo-crinol Metab 1994; 78: 114-1 2 0.
16. Karanikas G, Moameni A, Poetzi C et al: Frequency and relevance of elevated calcitonin levels in patients with neoplastic and non-neoplastic thyroid disease and in healthy subjects. J Clin Endocrinol Metab 2004; 89: 515-519.
17. Tiegs RD, Body JJ, Barta JM, Heath H: Secretion and metabolism of monomeric human calcitonin: effects of age, sex, and thyroid damage. J Bone Minera l Res 1986; 1: 339-349.
18. D'Herbomez M, Caron P, Bauters C, et al: Reference range of serum calcitonin levels in humans: influence of calcitonin assays, sex, age and cigarette smoking. Eur J Endocrinol 2007; 157:749-755.
19. Bieglmayer C, Scheuba C, Niederle C, et al: Screening for medullary thyroid carcinoma: experience with different immunoassays for human calcitonin. Wien Klin Wochenschr 2001; 114:267-273.
20. Vlaeminck-Guillem V, D'Herbomez M, Pigny P, et al: Pseudohypoparathyroidism Ia and hypercalcitoninemia. J Clin Endocrinol Metab 2001; 86: 3091-3096.
21. Hurley DL, Tiegs RD, Wahner HW, Heath H: Axial and appendicular bone mineral density in patients with long-term deficiency or excess of calcitonin. N Engl J Med 1987; 317: 537-541.
22. Wuster C, Raue F, Meyer C, Bergmann M, Ziegler R: Long-term excess of endogenous calcitonin in patients with medullary thyroid carcinoma does not affect bone mineral density. J Endocrinol 1992; 134:141-147.
23. Wion-Barbot N, Schuffenecker I, Niccoli P et al: Results of the calcitonin stimulation test in normal volunteers compared with genetically unaffected members of MEN 2A and familial medullary thyroid carcinoma families. Ann Endocrinol 1997; 58:302-308.
24. Baloch Z, Carayon P, Conte-Devolx B, et al: Guidelines Committee, National Academy of Clinical Biochemistry. Laboratory medicine practice guidelines. Laboratory support for the diagnosis and monitoring of thyroid. Thyroid 2003; 13:3-126.
25. Niccoli P, Wion-Barbot N, Caron P, et al: Interest of routine measurement of serum cal-citonin (CT): study in a large serie of thy-roïdectomized patients J Clin Endocrinol. Metab 1997; 82: 3 3 8-3 4 1.